A new, single-jab coronavirus vaccine developed by Pfizer-BioNTech, of which Hungary has so far received 109,000 doses, will be first used as a booster for vaccinated health-care workers, according to koronavirus.gov.hu.
The vaccine will be available for the Hungarian public from next week. Government offices are also assessing demand in care homes, it said. Hungary has ordered 9.5 million doses of the vaccine in a European Union purchase programme launched in wake of the spread of the Omicron variant. It is expected to receive 3 million doses this year and 6.5 million in 2023. Of the latter, 1.5 million doses will be optimised for children, the website said.